Bevacizumab
Mvasi is a brand-name biosimilar medication referencing Avastin, belonging to the class of vascular endothelial growth factor (VEGF) inhibitors. It works by targeting and blocking VEGF, a protein that promotes blood vessel formation in tumors, thereby inhibiting tumor growth and spread. This medication is used to treat various types of cancer, including certain forms of colorectal, lung, kidney, cervical, ovarian, and brain cancers.
Mvasi is a cancer treatment biosimilar that inhibits tumor blood vessel growth by blocking VEGF, used for multiple cancer types.
Key facts at a glance
- RxNorm
- 2046141
- Generic
- Mvasi
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Mvasi is used to treat metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, metastatic renal cell carcinoma, cervical cancer, epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
Mvasi is a monoclonal antibody that specifically binds to vascular endothelial growth factor (VEGF), preventing it from interacting with VEGF receptors on endothelial cells. This inhibition blocks the signaling pathway that promotes angiogenesis (formation of new blood vessels), effectively starving tumors of the blood supply needed for growth and metastasis.
Mvasi is administered as an intravenous infusion by a healthcare professional and is not a chemotherapy agent but a targeted biologic therapy. Common serious side effects include bleeding, blood clots, hypertension, wound healing complications, and gastrointestinal perforation. It should not be used during pregnancy. Patients require regular monitoring during treatment, and it may interact with other medications.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy